Skip to main content
. 2024 Nov 25;16(23):3944. doi: 10.3390/cancers16233944

Table 2.

Upregulated lncRNAs and circRNAs mediating TKI-resistance in HCC.

lncRNAs Target Mechanism References
MALAT1 miR-140-5p Increased Aurora kinase A [134]
THOR β-catenin Stabilizes β-catenin and increases CSCs [135]
NEAT1 miR-335 Activates c-MET and AKT pathways [136]
TRERNA1 miR-22-3p Increased NRAS and activation of RAF/MEK/ERK pathway [137]
LINC-ROR miR-876-5p Increased FOXM1 [138]
ZFAS1 Not identified Increased stemness and EMT [139]
linc-VLDLR Not identified Increased ABCG2 [140]
BBOX1-AS1 miR-361-3p Increased PHF8 [141]
URB1-AS1 Ferritin Inhibition of ferroptosis [142]
circRNA-SORE miR-103a-2-5p and miR-660-3p; YBX1 Activation of Wnt/β-catenin signaling pathway; stabilization of YBX1 [143,144]
circFOXM1 miR-1324 Increased MECP2 [145]
circDCAF8 miR-217 Increased NAP1L1 [146]